The Economic Times

The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that remain out of reach, the affordability crisis runs deep. A proposed cap may help, but question remains if it will be enough to change the picture.